Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Aug 15;9(8):3623-3632.
eCollection 2017.

Peripheral blood Th9 cells reconstitution and its relationship with acute graft-versus-host disease after matched-sibling peripheral blood hematopoietic stem cell transplantation

Affiliations

Peripheral blood Th9 cells reconstitution and its relationship with acute graft-versus-host disease after matched-sibling peripheral blood hematopoietic stem cell transplantation

Nannan Pang et al. Am J Transl Res. .

Abstract

T helper type 9 (Th9) cells have recently been identified as a new effector T cell subset. This study is to analyze the reconstitution of Th9 cell after matched sibling peripheral blood hematopoietic stem cell transplantation (MS-PBSCT) and the relationship between Th9 cell and acute graft-versus-host disease (aGVHD). Flow cytometry and ELISA were used to analyze the percentages of Th9 cell, levels of IL-9, TGF-β, IFN-γ, and IL-4. The results showed that for patients without aGVHD, Th9 cells recovery started from day 60 after transplantation and reached normal level on day 90. Serum TGF-β, IL-4, and IFN-γ reached normal levels on day 60, 60, and 90 post transplantation respectively. The serum IL-9 recovery is slower than that of IFN-γ and IL-4. For patients suffering from aGVHD, they had declined Th9 cell numbers, lower IL-9 and TGF-β levels, but higher serum IFN-γ level when compared with those without aGVHD after transplantation. Serum IFN-γ/IL-9 ratios increased linearly with grades of aGVHD. In conclusion, Th9 cells recovery is delayed after MS-PBSCT in patients with aGVHD but early in patients without aGVHD, indicating quick immune reconstitution of Th9 cells and IL-9 after MS-PBSCT may promote the immune tolerance.

Keywords: Allogeneic peripheral blood hematopoietic stem cell transplantation (allo-PBSCT); IL-9; Th9 cells; acute graft-versus-host disease (aGVHD).

PubMed Disclaimer

Conflict of interest statement

None.

Figures

Figure 1
Figure 1
Changes of Th9 cell in patients at various time points after MS-PBSCT. Subtypes of CD4+ IL-9+ Th9 cells in peripheral blood were detected by flow cytometry. Cells were first gated on CD3+ T cells and then on CD4+ IL-9+ T cells. A. The representative flow cytometric dot-plots of CD4+ IL-9+ Th9 cells in the blood of the control, 30-day, 60-day, 90-day and 150-day after transplantation. Numbers within each quadrant indicated percentages of cells within each dot-plot. B. Comparisons of the percentages of CD4+ IL-9+ Th9 cells in the peripheral blood. C. Comparisons of the percentages of Th9 cell in the peripheral blood of the HC, and patients after transplantation. The horizontal bars indicated means. Comparison was performed using one-way analysis of variance. HC: healthy controls. MS-PBSCT: matched-sibling peripheral blood hematopoietic stem cells transplantation.
Figure 2
Figure 2
Serum cytokine levels in patients without aGVHD after transplantation. Serum levels of IL-9, IFN-γ, TGF-β, and IL-4 in the patients from the MS-PBSCT group (on days 30, 60, 90, and 150 after transplantation), as well as in the healthy control (HC) subjects, were detected with ELISA. Compared with the HC group, *P < 0.05; compared with day 30 after transplantation, ΔP < 0.05; compared with the day 60 after transplantation, ※P < 0.05.
Figure 3
Figure 3
Dynamic change of IL-9, IFN-γ, TGF-β, and IL-4 in patients without aGVHD. IL-9 and TGF-β levels were significantly increased and then gradually recovered after transplantation.
Figure 4
Figure 4
Correlation analysis of cytokines in patients without aGVHD after transplantation. Data was analyzed with Spearman correlation analysis. IL-9 was positively correlated with the concentration of TGF-β (P=0.000, r=0.381), but not IFN-γ (P=0.561) and IL-4 (P=0.298).
Figure 5
Figure 5
Th9 cell percentage and associated cytokine levels in patients with or without aGVHD after transplantation. (A) Th9 cell percentage in the patients with or without aGVHD. Serum levels of IL-9 (B), TGF-β (C), IFN-γ (D), and IL-4 (E) in the patients with or without aGVHD after transplantation were detected with ELISA. In the aGVHD(+) group, IL-9 and TGF-β concentration was lower in the aGVHD(+) group than in aGVHD(-) group, but IFN-γ concentration was higher in the aGVHD(+) group.
Figure 6
Figure 6
Correlation between the IFN-γ/IL-9 ratio and aGVHD grade. Correlation between the IFN-γ/IL-9 ratio and aGVHD grade was analyzed by the Spearman correlation analysis. Patients without aGVHD (grade 0), patients with mild aGVHD (grade 1 to 2), patients with sever aGVHD (grade 3 to 4). IFN-γ/IL-9 ratio was positively correlated with the severity of aGVHD (P=0.000, r=0.723).

References

    1. Alfraih F, Aljurf M, Fitzhugh CD, Kassim AA. Alternative donor allogeneic hematopoietic cell transplantation for hemoglobinopathies. Semin Hematol. 2016;53:120–128. - PubMed
    1. Malard F, Labopin M, Stuhler G, Bittenbring J, Ganser A, Tischer J, Michallet M, Kröger N, Schmid C, Huynh A, Hallek M, Savani BN, Mohty M, Nagler A. Sequential intensified conditioning regimen allogeneic hematopoietic stem cell transplantation in adult patients with intermediate- or high-risk acute myeloid leukemia in complete remission: a study from the acute leukemia working party of the European group for blood and marrow transplantation. Biol Blood Marrow Transplant. 2016;23:278–284. - PubMed
    1. Fu J, Heinrichs J, Yu XZ. Helper T-cell differentiation in graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Arch Immunol Ther Exp (Warsz) 2014;62:277–301. - PubMed
    1. Welniak LA, Blazar BR, Murphy WJ. Immunobiology of allogeneic hematopoietic stem cell transplantation. Annu Rev Immunol. 2007;25:139–170. - PubMed
    1. Broady R, Yu J, Chow V, Tantiworawit A, Kang C, Berg K, Martinka M, Ghoreishi M, Dutz J, Levings MK. Cutaneous GVHD is associated with the expansion of tissue-localized Th1 and not Th17 cells. Blood. 2010;116:5748–5751. - PubMed

LinkOut - more resources